Cargando…
TPL2 mediates autoimmune inflammation through activation of the TAK1 axis of IL-17 signaling
Development of autoimmune diseases, such as multiple sclerosis and experimental autoimmune encephalomyelitis (EAE), involves the inflammatory action of Th1 and Th17 cells, but the underlying signaling mechanism is incompletely understood. We show that the kinase TPL2 is a crucial mediator of EAE and...
Autores principales: | Xiao, Yichuan, Jin, Jin, Chang, Mikyoung, Nakaya, Mako, Hu, Hongbo, Zou, Qiang, Zhou, Xiaofei, Brittain, George C., Cheng, Xuhong, Sun, Shao-Cong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Rockefeller University Press
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4113941/ https://www.ncbi.nlm.nih.gov/pubmed/24980047 http://dx.doi.org/10.1084/jem.20132640 |
Ejemplares similares
-
TPL2 mediates IL-17R signaling in neuroinflammation
por: Xiao, Yichuan, et al.
Publicado: (2015) -
Epigenetic regulation of Il12 and Il23 gene expression and autoimmune inflammation by the deubiquitinase Trabid
por: Jin, Jin, et al.
Publicado: (2016) -
Peli1 promotes microglia-mediated CNS inflammation by regulating Traf3 degradation
por: Xiao, Yichuan, et al.
Publicado: (2013) -
TBK1 controls IgA class switching by negatively regulating noncanonical NF-κB signaling
por: Jin, Jin, et al.
Publicado: (2012) -
USP15 stabilizes MDM2 to mediate cancer cell survival and inhibit antitumor T cell responses
por: Zou, Qiang, et al.
Publicado: (2014)